Moderna Inc.

Statistics report about biotech company Moderna

Moderna Inc.

This report presents key facts and figures about U.S. biotech company Moderna. Moderna Inc. is well-known for the discovery of one of the first two COVID-19 vaccines which was available to the broader market. This report shows the company's role in global biotech, revenues, major products, and provides a focus chapter on the COVID-19 vaccine market.

Table of contents

Market overview

6
  • Premium Statistic Global biotech drug sales estimate 2012-2024
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
  • Basic Statistic Top pharmaceutical products by sales worldwide 2023
  • Premium Statistic Forecasted revenue of mRNA market revenue worldwide 2021-2035
  • Premium Statistic Gross profit margin of select U.S. biotech and drugs companies Q3 2024
  • Basic Statistic AI readiness of big pharma companies 2023

Key figures

5
  • Basic Statistic Moderna's revenue 2016-2024
  • Basic Statistic Moderna net income 2016-2023
  • Basic Statistic Moderna total assets 2016-2023
  • Basic Statistic R&D expenses of Moderna 2016-2024
  • Basic Statistic R&D expenses of Moderna by type 2024

Competitors

4
  • Basic Statistic Leading mRNA biotech companies' market cap 2025
  • Basic Statistic Revenue of BioNTech 2017-2024
  • Premium Statistic AstraZeneca total revenue 2006-2024
  • Premium Statistic Pfizer revenue 2006-2024

Focus: COVID-19

8
  • Basic Statistic Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
  • Premium Statistic Forecasted COVID-19 vaccine revenue share globally by technology 2026
  • Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
  • Basic Statistic COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
  • Basic Statistic Comparison of select COVID-19 vaccines 2022, by efficacy
  • Premium Statistic Shareholdings at select COVID-19 vaccine companies by investor 2021
  • Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
  • Premium Statistic Share of Moderna COVID-19 vaccines delivered by country income group 2021

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Contact

Get in touch with us. We are happy to help.

Meredith Alda
Sales Manager– Contact (United States)
Tel
+1 914 619-5895

Mon - Fri, 9am - 6pm (EST)

Yolanda Mega
Operations Manager– Contact (Asia)
Tel
+65 6995 6959

Mon - Fri, 9am - 5pm (SGT)

Ayana Mizuno
Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Lodovica Biagi
Director of Operations– Contact (Europe)
Tel
+44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm (GMT)

Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Tel
+1 212 419-5774

Mon - Fri, 9am - 6pm (EST)